Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
763.98 | -47.9% | -26.52% | 682,237.16 | 0.69% | 2.63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
910.00 | -1.78% | 18.6% | 4,053,455.72 | 1.03% | 18.5% |
|
NYSE:JNJ
Johnson & Johnson
|
151.38 | 0% | 0% | 363,938.03 | 3.28% | 2.71% |
|
NYSE:MRK
Merck
|
128.66 | -8.69% | 4.69% | 327,466.53 | 2.38% | -19.03% |
|
NYSE:ABBV
AbbVie
|
161.59 | -20.61% | -10.12% | 284,799.16 | 3.84% | 7.03% |
|
LSE:AZN
AstraZeneca PLC
|
122.46 | 16.88% | 39.22% | 190,957.95 | 2% | 15.98% |
|
SWX:NOVN
Novartis
|
93.49 | 8.5% | 21.92% | 189,900.62 | 3.55% | 4.67% |
|
SWX:ROG
Roche Holding
|
224.60 | 30.46% | 46.37% | 183,894.9 | 4.21% | 0.43% |
|
NYSE:DHR
Danaher
|
259.26 | -16.08% | -4.94% | 186,364.14 | 0.42% | 10.89% |
|
NasdaqGS:AMGN
Amgen
|
311.41 | -11.11% | -2.21% | 165,463.28 | 2.92% | 5.31% |
|
NYSE:PFE
Pfizer
|
28.38 | 9.18% | 39.63% | 161,157.9 | 5.91% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
91.69 | 14.77% | 33.02% | 115,761.94 | 4.06% | 8.19% |
|
NYSE:MDT
Medtronic
|
84.30 | 27.72% | 40.94% | 110,899.74 | 3.3% | 2.09% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
428.59 | 1.37% | 9.4% | 110,944.89 | 0% | 30.14% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
984.64 | -29.21% | -23.18% | 105,399.82 | 0% | 13.9% |
|
LSE:GSK
GSK
|
18.10 | 5.36% | 20.88% | 73,812.48 | 3.2% | 0.79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.71 | 58.04% | 68.14% | 91,341.13 | 5.33% | 13.54% |
|
ASX:CSL
CSL
|
279.58 | 22.63% | 43.58% | 135,272.1 | 1.28% | 7.18% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.65 | 21.22% | 30.5% | 84,144.93 | 4.56% | 0.15% |
|
NYSE:ZTS
Zoetis
|
168.87 | 31.76% | 48.08% | 76,616.52 | 1.03% | 11.19% |
